GlassScriptPhysician profile
Danielle N Grabovich
NPI 1649718230
$2,572.71
in general payments reported to CMS, 2019-2025
19 companies · $611 in 2025
The $611 reported for 2025 was more than what 80% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $805 · 2023: $997 · 2024: $34.94 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,643.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $456.23 | 2022-2025 | Coroflow, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $377.28 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $312.56 | 2022-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $213.68 | 2022-2023 | Xarelto |
| Pfizer INC. | $209.57 | 2022-2023 | |
| Heartflow, INC. | $182.06 | 2023 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $158.32 | 2022-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $131.05 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $117.02 | 2021 | |
| Angiodynamics, INC. | $83.85 | 2025 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $83.58 | 2022-2023 | Repatha |
| Medtronic, INC. | $60.12 | 2025 | Hawkone |
| Novo Nordisk INC | $43.02 | 2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $32.87 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $31.00 | 2023 | Inpefa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $30.45 | 2023 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $21.60 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.26 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $14.19 | 2025 | Capvaxive, Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Grabovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.